Trials / Completed
CompletedNCT05892939
Effects of Intranasal Oxytocin on Fear Processing in Naturalistic Contexts
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- University of Electronic Science and Technology of China · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The main aim of the study is to investigate the modulatory effects of intranasal oxytocin (24IU) on fear in naturalistic social and non-social contexts and the underlying neural mechanisms.
Detailed description
In a double-blind placebo-controlled between-subject experimental design, 60 adult male subjects will be randomly allocated to receive either intranasal oxytocin (24IU, n= 30) or placebo (n = 30) nasal spray. 45 minutes after treatment the participants will undergo a naturalistic fear induction paradigm during fMRI. During the paradigm video clips of 25s lengths will be presented showing fear-inducing situations in social and non-social contexts as well as corresponding control video clips. Following each clip subjects are required to rate their level of subjective fear on a rating scale ranging from 1 (no fear) to 9 (highest fear). Participants will undergo screening for psychopathological and emotional states before treatment. Together with a randomized assignment to the treatment groups, this will allow controlling for confounding between-group differences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intranasal Oxytocin(24IU) | Administration of intranasal Oxytocin(24IU) |
| DRUG | intranasal Placebo | Administration of intranasal Placebo |
Timeline
- Start date
- 2023-05-23
- Primary completion
- 2024-04-01
- Completion
- 2024-04-15
- First posted
- 2023-06-07
- Last updated
- 2025-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05892939. Inclusion in this directory is not an endorsement.